# Hypertonic Saline for Fluid Resuscitation After Cardiac Surgery

> **NCT03280745** · PHASE4 · COMPLETED · sponsor: **Insel Gruppe AG, University Hospital Bern** · enrollment: 165 (actual)

## Conditions studied

- Cardiovascular Diseases
- Valvular Heart Disease

## Interventions

- **DRUG:** Hypertonic saline
- **DRUG:** 0.9% saline

## Key facts

- **NCT ID:** NCT03280745
- **Lead sponsor:** Insel Gruppe AG, University Hospital Bern
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-02-27
- **Primary completion:** 2019-05-27
- **Final completion:** 2019-09-30
- **Target enrollment:** 165 (ACTUAL)
- **Last updated:** 2020-03-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03280745

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03280745, "Hypertonic Saline for Fluid Resuscitation After Cardiac Surgery". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03280745. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*